Trade

with

Edwards Lifesciences Corp
(NYSE: EW)
AdChoices
105.81
+3.94
+3.87%
After Hours :
105.81
0.00
0.00%

Open

102.27

Previous Close

101.87

Volume (Avg)

871.99k (990.70k)

Day's Range

102.27-106.17

52Wk Range

60.62-108.73

Market Cap.

11.22B

Dividend Rate ( Yield )

-

Beta

0.55

Shares Outstanding

106.03M

P/E Ratio (EPS)

15.27 (6.93)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Medical Devices
Highlights
Analyst Recommendation: Hold
    • Revenue

    • 2.05B

    • Net Income

    • 391.70M

    • Market Cap.

    • 11.22B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 35.78

    • PEG (Price/Earnings Growth) Ratio

    • 7.11

    • Beta

    • 0.55

    • Forward P/E

    • 27.55

    • Price/Sales

    • 5.46

    • Price/Book Value

    • 5.86

    • Price/Cash flow

    • 9.65

      • EBITDA

      • 593.80M

      • Return on Capital %

      • 26.89

      • Return on Equity %

      • 43.60

      • Return on Assets %

      • 26.89

      • Book Value/Share

      • 18.06

      • Shares Outstanding

      • 106.03M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/20/2014
      Hold
        • 1 Year Price Target

        • 105.00

        • Credit Rating

        • BBB+

        • Analysts

        • 4

        • EPS Estimate

        • 3.72

        • Cashflow Estimate

        • 4.14

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 11.20

          • 2.66

          • Net Income

            YTD/YTD (last year)

          • 33.60

          • -22.64

          • Net Income

            Q/Q (last year)

          • 486.30

          • -29.83

          • Sales (Revenue)

            5-Year Annual Average

          • 10.57

          • 4.60

          • Net Income

            5-Year Annual Average

          • 24.90

          • -1.34

          • Dividends

            5-Year Annual Average

          • -

          • -0.25

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 73.00

            • 64.08

            • Pre-Tax Margin

            • 51.42

            • 15.19

            • Net Profit Margin

            • 35.78

            • 13.09

            • Average Gross Margin

              5-Year Annual Average

            • 72.20

            • 65.03

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 20.80

            • 17.99

            • Average Net Profit Margin

              5-Year Annual Average

            • 16.20

            • 191.75B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.31

              • 0.34

              • Current Ratio

              • 4.21

              • 2.55

              • Quick Ratio

              • 3.35

              • 1.83

              • Interest Coverage

              • 69.42

              • 11.70

              • Leverage Ratio

              • 1.74

              • 1.86

              • Book Value/Share

              • 18.06

              • 11.69

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 14.71

                • 34.01

                • P/E Ratio 5-Year High

                • 15.99

                • 224.03

                • P/E Ratio 5-Year Low

                • 5.11

                • 60.23

                • Price/Sales Ratio

                • 5.26

                • 3.17

                • Price/Book Value

                • 5.64

                • 3.20

                • Price/Cash Flow Ratio

                • 9.65

                • 18.42

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 43.60

                    (20.90)

                  • 12.33

                    (18.16)

                  • Return on Assets %

                    (5-Year Average)

                  • 26.89

                    (14.10)

                  • 6.62

                    (8.69)

                  • Return on Capital %

                    (5-Year Average)

                  • 35.78

                    (18.20)

                  • 8.49

                    (11.48)

                  • Income/Employee

                  • 88.58k

                  • 34.11k

                  • Inventory Turnover

                  • 1.86

                  • 2.77

                  • Asset Turnover

                  • 0.75

                  • 0.51

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  454.50M
                  Operating Margin
                  22.22
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  9.65
                  Ownership

                  Institutional Ownership

                  92.60%

                  Top 10 Institutions

                  53.85%

                  Mutual Fund Ownership

                  53.13%

                  Float

                  73.43%

                  5% / Insider Ownership

                  1.12%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • VA CollegeAmerica Growth Fund of America

                  •  

                    6,132,700

                  • -24.13

                  • 5.78

                  • Vanguard Health Care Fund

                  •  

                    4,920,000

                  • -7.59

                  • 4.64

                  • VA CollegeAmerica AMCAP

                  •  

                    3,972,900

                  • 0.00

                  • 3.75

                  • Vanguard Mid-Cap Index Fund

                  •  

                    1,813,966

                  • 1.61

                  • 1.71

                  • Vanguard Total Stock Mkt Idx

                  •  

                    1,731,867

                  • 1.08

                  • 1.63

                  • VA CollegeAmerica Fundamental Investors

                  •  

                    1,700,000

                  • -48.48

                  • 1.60

                  • American Funds NVIT Growth-Income Fund

                  •  

                    1,528,900

                  • -1.61

                  • 1.44

                  • American Funds NVIT Growth

                  •  

                    1,440,400

                  • -52.62

                  • 1.36

                  • Fidelity® Mid-Cap Stock Fund

                  •  

                    1,201,400

                  • 0.00

                  • 1.13

                  • UniGlobal

                  •  

                    1,104,395

                  • 8.66

                  • 1.04

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Capital World Investors

                  •  

                    12,123,400

                  • -3.19%

                  • 11.44

                  • Capital Research Global Investors

                  •  

                    10,763,100

                  • -18.84%

                  • 10.15

                  • Vanguard Group, Inc.

                  •  

                    7,427,673

                  • -0.35%

                  • 7.01

                  • Fidelity Management and Research Company

                  •  

                    6,682,456

                  • -12.39%

                  • 6.30

                  • Wellington Management Company, LLP

                  •  

                    4,953,200

                  • -6.96%

                  • 4.67

                  • State Street Corp

                  •  

                    4,624,367

                  • -0.71%

                  • 4.36

                  • Generation Investment Management LLP

                  •  

                    4,272,320

                  • +78.50%

                  • 4.03

                  • BlackRock Fund Advisors

                  •  

                    3,156,566

                  • -0.78%

                  • 2.98

                  • Fairpointe Capital LLC

                  •  

                    1,616,848

                  • -48.83%

                  • 1.53

                  • Union Investment Privatfonds GmbH

                  •  

                    1,457,459

                  • +13.25%

                  • 1.38

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Medical Devices

                  Type

                  Aggressive Growth

                  Style

                  Mid Growth

                  Edwards Lifesciences Corp was incorporated in Delaware on September 10, 1999. The Company is the manufacturer of heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. It is also a g...morelobal leader in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. It conducts operations worldwide and are managed in the following geographical regions: United States, Europe, Japan and Rest of World. The products and technologies provided by the Company to treat advanced cardiovascular disease or critically ill patients are categorized into the following main areas: Surgical Heart Valve Therapy, Transcatheter Heart Valves, and Critical Care. The Company's Surgical Heart Valve Therapy portfolio includes tissue he...moreart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve. The portfolio also includes a diverse line of cardiac surgery systems used during minimally invasive surgical procedures, and cannulae, embolic protection devices and other products used during cardiopulmonary bypass. The Company's Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques. In the Critical Care portfolio, Edwards Lifesciences' products include pulmonary artery catheters, disposable pressure transducers and advanced monitoring systems. The portfolio also includes a line of balloon catheter-based vascular products, surgical clips and inserts. The Company competes with many companies, including divisions of companies much larger than it and smaller companies that compete in specific product lines or certain geographies. The Company’s Surgical Heart Valve Therapy and Transcatheter Heart Valve products are manufactured in California and Utah in the United States, Switzerland, and Singapore. Critical Care products are manufactured primarily in its facilities located in Puerto Rico and the Dominican Republic. The Company’s products and technologies are subject to regulation by numerous domestic and foreign government agencies, including the FDA, and various laws and regulations governing the development, testing, manufacturing, labeling, marketing and distribution of its products and technologies.lessless

                  Key People

                  Michael A. Mussallem

                  CEO/Chairman of the Board/Director

                  Scott B. Ullem

                  CFO/Vice President

                  Aimee S. Weisner

                  General Counsel/Vice President

                  Donald E. Bobo,Jr

                  Vice President, Divisional

                  Larry L. Wood

                  Vice President, Divisional

                  • Edwards Lifesciences Corp

                  • One Edwards Way

                  • Irvine, CA 92614

                  • USA.Map

                  • Phone: +1 949 250-2500

                  • Fax: +1 949 250-2525

                  • edwards.com

                  Incorporated

                  1999

                  Employees

                  8,600

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: